Daily Stock List
OrganiGram Holdings, Inc. (OGRMF)
CFN Media Group and Cannabis Financial Network News reported recently on OrganiGram Holdings, Inc. (OGRMF), Wealth Daily and Money Morning did previously, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 2013, OrganiGram Holdings, Inc.’s emphasis is on producing the highest quality, condition specific medical marijuana for patients in Canada. The Company’s wholly-owned subsidiary, OrganiGram, Inc., is a licensed producer of medical marijuana in Canada. OrganiGram's head office, production facility, and Research and Development (R&D) is in Moncton, New Brunswick. The Company is regulated by the Marihuana for Medical Purposes Regulations. OrganiGram Holdings’ shares trade on the OTC Markets’ Group’s OTCQB.
The Company’s facility consists of two buildings on 5.5 acres. It consists of 78,500 sq. ft. of production space at full build out. OrganiGram has made a more than $8,500,000 capital investment.
All of OrganiGram Holdings’ products are made under strict controls and in conformance with the Good Production Practices of the MMPR, and the security directives as defined by the Office of Controlled Substances. All are lab tested before packaging and sale.
The Company has collaborations with healthcare experts and academic institutions. OrganiGram invests in medical education, outreach, as well as research for the use of cannabinoids as a first line of treatment.
OrganiGram offers a varied assortment of genetics and product types. These cater to the individual needs of each and every client. The Company offers a reliable supply of premium-quality, industry-leading strains to match individuals’ personal requirements.
Last month, OrganiGram Holdings announced a collaboration with the Province of New Brunswick by way of Opportunities NB, Inc. (ONB). Under a payroll rebate agreement, OrganiGram may earn payroll rebates up to a maximum of $ 990,000 over a 3-year period.
OrganiGram employs 43 full-time staff at its location in Moncton. At present, the Company is expanding to meet growth in the medicinal marijuana field while devising further expansion plans regarding forthcoming guidance from the Federal Government concerning a recreational marketplace. Organigram’s business plan foresees considerable expansion in its employee base in Moncton during the term of the agreement.
Yesterday, OrganiGram Holdings provided a preliminary synopsis of its Q2 results. Highlights from the financial results for the quarter include a 38 percent increase in revenue, a 14 percent improvement in gross margin percentage and the attainment of positive year-to-date (YTD) EBITDA and cash flow from operations. The expectation is that full financial statements for the quarter ending February 29, 2016 will be released on April 25, 2016.
OrganiGram Holdings, Inc. (OGRMF), closed Wednesday's trading session at $0.75, up 10.29%, on 100,318 volume with 74 trades. The average volume for the last 60 days is 18,485 and the stock's 52-week low/high is $0.1628/$1.0584.
Implant Sciences Corp. (IMSC)
PennyStockProphet, Stock Onion, Penny Pick Finders, PennyStockLocks.com, StockRockandRoll, ResearchOTC, Buzz Stocks, Planet Penny Stocks, PennyPickAlerts, and Fortune Stock Alerts reported on Implant Sciences Corp. (IMSC), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Implant Sciences Corp. is a high technology supplier of systems and sensors for homeland security and defense markets. The Company is a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications. Implant has developed proprietary technologies used in its commercial explosives and drugs trace detection systems that ship to an increasing number of locations domestically and around the world.
In January 2013, Implant Sciences became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant develops and makes explosive trace detection sensors and systems, which can detect minute amounts of a broad array of military, commercial, as well as homemade explosives.
The Company’s patented technologies provide innovative screening capabilities to extend and improve counter-terrorist and homeland security efforts. All of its products have recognition as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. Implant’s QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation.
The QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology. It is built with no radioactive materials and features a low-maintenance, self-calibrating, and self-clearing design. The QS-H150 provides very high levels of operational availability. It has been proven to perform well in a wide variety of temperatures and challenging environments.
The Company’s QS-B220 received TSA qualification for air cargo screening. The QS-B220 features a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system. Moreover, QS-B220 received STAC certification, a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act).
Implant Sciences’ ETDs have received approvals and certifications from many global regulatory agencies. These include the TSA in the United States, ECAC in Europe, STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. In 2015, Implant Sciences announced that its QS-B220 explosives and drugs trace detector received regulatory approval in Russia for transportation.
Recently, Implant Sciences announced that it shipped around $1 million of its QS-B220 desktop explosives and drugs trace detectors and its QS-H150 handheld explosives trace detectors. A large part of these sales, which were earlier unannounced, were shipped to fulfill additional demand for aviation security in European nations. Over the past year, Implant Sciences has been chosen by high profile airports across 14 EU countries and has deployed more than1,000 units to support ECAC regulations.
Implant Sciences Corp. (IMSC), closed Wednesday's trading session at $0.419, down 10.99%, on 1,254,272 volume with 255 trades. The average volume for the last 60 days is 179,563 and the stock's 52-week low/high is $0.245/$0.85.
Catasys, Inc. (CATS)
The Street, Stock Gumshoe, PennyPickAlerts, Investopedia, Fortune Stock Alerts, and TopPennyStockMover reported earlier on Catasys, Inc. (CATS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Catasys, Inc. is a provider of proprietary health management services to health insurers and employers. The Company provides specialized health management services by way of a network of licensed and company managed health care providers. Catasys established to serve health care payors, and it provides unique and integrated substance dependence treatment solutions for its members. Catasys has its headquarters in Los Angeles, California.
The Catasys substance dependence program improves member health, therefore decreasing overall costs. The proprietary program addresses substance dependence as a chronic disease. The program focuses on the whole health of the member. The program delivers integrated medical and psychosocial interventions in combination with long-term care coaching.
Catasys provides its proprietary OnTrak integrated substance dependence solutions for third-party payors in numerous states. The design of Catasys’ OnTrak program is to improve member health and at the same time lessen costs to the insurer through employing patient centric treatment that integrates evidence based medical and psychosocial interventions along with care coaching in a 52-week outpatient program.
Catasys has contracted to expand to the state of Illinois. OnTrak is improving member health and, simultaneously, is demonstrating reduced inpatient and emergency department utilization driving a greater than 50 percent reduction in total health care costs for enrolled members.
Recently, Catasys announced that it launched its OnTrak™-H solution in Illinois with one of the country’s foremost health plans. The plan's eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, and also intensive care coaching.
Catasys' President and COO, Mr. Rick Anderson, said, "We are excited to now provide our OnTrak-H solution to eligible Medicare Advantage members in Illinois. This represents the sixth state in which we have announced the launch of the OnTrak-H program and the third leading health plan to partner with us in the state of Illinois."
Catasys, Inc. (CATS), closed Wednesday's trading session at $0.75, up 25.06%, on 180,592 volume with 87 trades. The average volume for the last 60 days is 13,158 and the stock's 52-week low/high is $0.245/$2.10.
Cannabis Sativa, Inc. (CBDS)
Darwin Investing Network, Wall Street Mover, Stock Beast, Cannabis Financial Network News, Greenbackers, TheMicrocapNews, TopStockAnalysts, Flagler Financial Group, smartOTC, and Real Pennies reported on Cannabis Sativa, Inc. (CBDS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cannabis Sativa, Inc. involves in branding and licensing via its 'hi' intellectual properties. The Company engages, through its subsidiaries, Wild Earth Naturals and "hi" Brands International, Inc., in the research, development, and licensing of specialized natural products. These include formulas, edibles, topicals, recipes, and delivery systems. Cannabis Sativa is based in Mesquite, Nevada.
The Company brands, licenses, innovates, and markets premier plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and additionally legal nutraceuticals and branded merchandise for consumers in general. Its goal is to license the "hi" brand to distributors and producers of quality products and to other ancillary participants in the retail cannabis industry.
Cannabis Sativa has its Wild Earth Naturals offerings. The Company offers the Wild Earth Naturals line of CBD Water and cosmetic products designed to use organic and natural ingredients. These include CBD and hemp seed oil.
Cannabis Sativa’s wholly-owned subsidiary, Hi Brands International, entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Their CBD capsules are marketed under the name, "hi CBD." Each capsule contains 7.5 mg of water-soluble CBD and sells in bottles of 60 capsules, which constitutes the recommended monthly usage of two capsules daily.
Cannabis Sativa’s Hi Brands International entered into a strategic joint venture with the developer of a pharmacy discount card to distribute the card under its "HI" brand. The card is a prescription discount card. It will be marketed as the HI BENEFITS Discount Prescription Card or HI Benefits Discount Rx Card. The HI Benefits Discount Rx Card is now totally functional. It may be used across the U.S. and globally. Additional benefits will be added in the future. These benefits will be available to Cannabis Sativa member card holders.
This past February, Cannabis Sativa announced that HI Brands International entered into a trademark and licensing agreement with Trike Candy LLC (an Oregon Limited Liability Company-LLC) to brand hi chocolate bars for the Oregon recreational marijuana market. Trike Candy is licensed to process marijuana infused products in Oregon for sale in the recreational marijuana market.
This month, Cannabis Sativa announced that Senator Mike Gravel will take over as Chief Executive Officer (CEO) of Cannabis Sativa. Former interim CEO, Mr. David Tobias, said, "As an active and outspoken member of the CBDS Board of Directors, Senator Mike Gravel is familiar with the executive side of operations, and his wealth of experience with public policies, politics and private business make him an outstanding choice and a fortuitous acquisition to our management team." Mr. Tobias will transition to the position of President of Cannabis Sativa.
Cannabis Sativa, Inc. (CBDS), closed Wednesday's trading session at $1.91, down 5.45%, on 236,854 volume with 349 trades. The average volume for the last 60 days is 220,820 and the stock's 52-week low/high is $0.30/$5.65.
Endonovo Therapeutics, Inc. (ENDV)
HEROSTOCKS, Stock Brain, SmallCapVoice, StockOnion, PennyStockProphet, SecretStockPromo, Damn Good Penny Picks, Planet Penny Stocks, Penny Pick Finders, Buzz Stocks, Stock Commander, PREPUMP STOCKS, Penny Stock Newsletter, Penny Picks, BestDamnPennyStocks, TheNextBigTrade, DSR News, and PHUB News reported on Endonovo Therapeutics, Inc. (ENDV), and today we also report on the Company, here at the QualityStocks Daily Newsletter.
Endonovo Therapeutics, Inc. is a biotechnology company headquartered in Woodland Hills, California. It is developing bioelectronic devices and therapies for regenerative medicine. The Company’s initial focus is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform and the treatment of Graft-Versus-Host Disease using its ex vivo expanded and enhanced stem cells. Endonovo Therapeutics is centering its efforts on inflammatory conditions in vital organs.
Endonovo Therapeutics’ Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure via the reduction of inflammation, cell death and the promotion of regeneration. The Company’s Cytotronics™ platform provides for a method of expanding and manipulating cells utilizing simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.
The aim of Endonovo’s Cytotronics™ platform is to create optimized cell-based therapies with greater therapeutic potential than the un-modulated cells presently being used in regenerative medicine. The foundation for the Company’s Time-Varying Electromagnetic Field (TVEMF) technology was created at NASA in combination with the development of cell therapies to treat injuries and diseases that astronauts might encounter during long term manned missions in space.
Endonovo Therapeutics previously announced it is in the pre-clinical phase of evaluating its proprietary Immunotronic technology in the treatment of chronic and acute inflammatory conditions in the liver, including fulminant liver failure. The Company is developing a next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronics™ expanded and ex vivo enhanced stem cells from the human umbilical cord. It previously announced a method and composition process for the creation of a cell mixture from a portion of the human umbilical cord co-cultured with adipose-derived stem cells.
The resulting cell mixture provides for a rich source of highly-proliferative, immunosuppressive and non-alloreactive cells. These display neither of the major histocompatibility markers (HLA double negative). These immune privileged cells therefore represent a major source of cells for allogeneic mesenchymal cell-based therapies.
Recently, Endonovo Therapeutics announced it received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application entitled "Biological Molecules Produced by Electromagnetically Stimulating Living Mammalian Cells." The patent application covers the production of biological molecules, including growth factors and cytokines in adult stem cells employing Endonovo’s proprietary technologies.
Today, Endonovo Therapeutics announced that its Chairman & CEO, Mr. Alan Collier, will present a Company and bioelectronics overview at the SeeThruEquity 5th Annual Microcap Investor Conference on May 31, 2016. The event will take place at Convene Conference Center at 730 3rd Avenue in New York, New York.
Endonovo Therapeutics, Inc. (ENDV), closed Wednesday's trading session at $0.54, up 20.00%, on 386,794 volume with 131 trades. The average volume for the last 60 days is 211,578 and the stock's 52-week low/high is $0.052/$1.00.
Giggles N' Hugs, Inc. (GIGL)
The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.0884, up 33.74%, on 32,874 volume with 7 trades. The stock’s average daily volume over the past 60 days is 34,937, and its 52-week low/high is $0.0137/$0.2799.
Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.
In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.
Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.
Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.
Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer
Giggles N' Hugs, Inc. Company Blog
Giggles N' Hugs, Inc. News:
Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview
Giggles Ní Hugs Signs Agreement with New York-Based Chardan Capital Markets
Giggles N Hugs to present at the 8th annual LD Micro Conference main event
eXp Realty International Corp. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp Realty International Corp. (EXPI). Today, eXp Realty International Corp. closed trading at $1.81, up 12.70%, on 30,504 volume with 38 trades. The stock’s average daily volume over the past 60 days is 9,850, and its 52-week low/high is $0.49/$2.20.
eXp Realty International Corp. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp Realty International Corp. Company Blog
eXp Realty International Corp. News:
eXp Realty International Corporation Announces Name Change to eXp World Holdings, Inc.
eXp Realty International Corporation Enters Into Agreement With VirBELA, LLC
eXp Realty International Corporation Appoints COO and CFO
Ecosciences, Inc. (ECEZ)
The QualityStocks Daily Newsletter would like to spotlight Ecosciences, Inc. (ECEZ). Today, Ecosciences, Inc. closed trading at $0.0431, up 7.75%, on 535,715 volume with 86 trades. The stock’s average daily volume over the past 60 days is 665,823, and its 52-week low/high is $0.0291/$0.75.
Ecosciences, Inc. (ECEZ) provides bio-remediation services for sewers, sludge ponds, septic tanks, lagoons, farms, car washes, portable sanitation facilities, grease tanks, lakes and ponds. The company's suite of tablet-based products effectively oxygenate wastewater, remove hydrogen sulfide odors, prevent corrosion and initiate the aerobic biological breakdown of various types of organic sludge. By utilizing the power of oxygen to efficiently treat wastewater systems, Ecosciences aims to minimize the need for expensive dosing equipment and hazardous chemicals while simultaneously reducing the costs of treating and removing organic solid wastes.
The company, through wholly-owned subsidiary Eco-logical Concepts, Inc., currently produces and sells a variety of bio-remediation products. Tank-Eze Wastewater Tablets are solid, sustained release tablets that provide active oxygen, nutrients, buffers and safe aerobic microorganisms that can be used in pump and lift stations, septic tank systems and other waste-water treatment systems. Trap-Eze Grease Trap Tablets can be used by a variety of food service industry customers to effectively clean and deodorize grease traps. Wash-Eze Car Wash Tablets reduce the noxious odors, spotting and other problems associated with the use of reclaimed water to wash vehicles. Ecosciences also markets Sept-Eze, an oxygen-enriched septic tank treatment solution.
In February 2016, Ecosciences unveiled a new acquisition-based growth strategy designed to augment its current business of wholesale and retail sales of its bio-remediation products. Through this strategy, the company plans to seek out acquisition candidates across various segments of the bio-remediation and janitorial industry in an effort to increase its existing customer base and accelerate future growth. As of its latest update, Ecosciences has commenced preliminary discussions with three potential acquisition targets, but it has not yet entered into any definitive agreements.
Through the use of distribution agreements, the company also remains focused on expanding the marketability of its existing product line. Ecosciences recently entered into a master distribution agreement with a janitorial supply firm based in the Dominican Republic that is expected to drive future growth in the Caribbean nation. The company also announced a distribution agreement with Everglades Supply Co. through which Everglades was granted the right to resell Ecosciences's products in the Northeastern Tri-State area of New York, New Jersey and Connecticut, as well as South Florida and the Middle East. Disclaimer
Ecosciences, Inc. Company Blog
Ecosciences, Inc. News:
Ecosciences, Inc. Signs Distributor Agreement With Everglades Supply Co, Inc.
Ecosciences, Inc. Signs Master Distributor Agreement With CONEAP for the Dominican Republic
Ecosciences, Inc. Unveils Acquisition Strategy
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.023, up 1.10%, on 1,238,078 volume with 38 trades. The stock’s average daily volume over the past 60 days is 1,488,881 and its 52-week low/high is $0.0035/$0.339.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Recognized as Leader in Expanding Fuel Cell Applications in U.S. Department of Energy (DOE) Report
Dominovas Energy Agrees to Acquire Grupo Trebol in Guatemala City, Guatemala
Dominovas Energy Signs Financing Agreement With GHS Capital
Alternet Systems, Inc. (ALYI)
The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.009, up 26.76%, on 35,606 volume with 5 trades. The stock’s average daily volume over the past 60 days is 118,668, and its 52-week low/high is $0.0055/$0.029.
Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.
Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets
Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.
Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.
With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.
As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer
Alternet Systems, Inc. Company Blog
Alternet Systems, Inc. News:
Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners
Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation
Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Signs Engagement Letter With Auditing Firm, BF Borgers CPA PC
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Signs MOU to Acquire Revenue-Producing Company
- Dominovas Energy Corp. (DNRG) Recognized as Leader in Expanding Fuel Cell Applications in U.S. Department of Energy (DOE) Report
- Ecosciences, Inc. (ECEZ) Signs Distributor Agreement With Everglades Supply Co, Inc.
- eXp Realty International Corp. (EXPI) Announces Name Change to eXp World Holdings, Inc.
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview
- GTX Corp. (GTXO) and COPsync Sign Mutual Referral Agreement for Products Targeting Law Enforcement and Safety
- Halitron, Inc. (HAON) Generates Over $1M in Sales
- Immune Therapeutics, Inc. (IMUN) Provides Drug Development Program Status Update on Methionine-Enkelphine ("MENK") in China
- International Stem Cell Corp. (ISCO) Announces 2015 Fourth Quarter and Year-End Results
- Laguna Blends Inc. (LAGBF) Initiates Phase One of LagunaWorld.com Virtual 3D Community and Introduces Charles Carleton as Head Technical Advisor of Laguna World
- Lingo Media Corp. (LMDCF) and Gale, a Part of Cengage Learning, Enter Into Global Distribution Partnership
- Moxian, Inc. (MOXC) Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate
- Oakridge Global Energy Solutions, Inc. (OGES) Successful First Quarter Q1, 2016 Revenues Exceed Guidance
- OurPet's Company (OPCO) Reaches a Settlement With Competitor Over Durapet(R) Patents
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust